This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Delayed clinical trial data delivery is a growing problem for pharmaceuticalcompanies and one that can have catastrophic consequences for the development of their promising pipeline candidates.
Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceuticalcompanies that spans teams, functions, and geographies. Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape.
A subsidiary of South Korean pharmaceuticalcompany Pharos iBio, Pharos will give the university’s drug discovery initiatives team access to Pharos iBio’s AI drug development platform, which is called Chemiverse. It will provide the drug discovery initiative access to advanced algorithms and 230 million big dataentries.
Fresenius Kabi is a global healthcare company specialising in medicines and technologies for infusion, transfusion and clinical nutrition. In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio.
Pharmaceuticalcompanies regularly transfer databases as they shift to new systems or change service providers in pursuit of higher quality and increased efficiency. These database transfer activities must follow industry standards and pharmacovigilance regulation, which has become increasingly stringent over the last decade.
From the assessment of past marketing campaigns to designing an effective and novel campaign, intelligent automation has truly revolutionized the ways of marketing Several pharmaceuticalcompanies have benefitted colossally by opening the door to automation. Companies need to adopt a holistic approach to exploit the best results.
Data integrity isn’t a software, service, or product; it encompasses various solutions contributing to improved data maintenance and quality. Importance of Data Integrity in the Pharma Industry It takes just one wrong dataentry, breach, or incident for patients and clients to lose your trust.
But before pharmaceuticalcompanies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Here are some ways companies are using AI in clinical trials. The need for new medical treatments and drugs has never been greater.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content